These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


333 related items for PubMed ID: 8726232

  • 1. Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activity.
    Holm BA, Wang Z, Egan EA, Notter RH.
    Pediatr Res; 1996 May; 39(5):805-11. PubMed ID: 8726232
    [Abstract] [Full Text] [Related]

  • 2. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
    Hall SB, Venkitaraman AR, Whitsett JA, Holm BA, Notter RH.
    Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593
    [Abstract] [Full Text] [Related]

  • 3. Dynamic surface activity of films of lung surfactant phospholipids, hydrophobic proteins, and neutral lipids.
    Wang Z, Hall SB, Notter RH.
    J Lipid Res; 1995 Jun; 36(6):1283-93. PubMed ID: 7666006
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Primary importance of zwitterionic over anionic phospholipids in the surface-active function of calf lung surfactant extract.
    Wang Z, Gurel O, Weinbach S, Notter RH.
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1049-57. PubMed ID: 9351602
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Surface activity of a synthetic lung surfactant containing a phospholipase-resistant phosphonolipid analog of dipalmitoyl phosphatidylcholine.
    Wang Z, Schwan AL, Lairson LL, O'Donnell JS, Byrne GF, Foye A, Holm BA, Notter RH.
    Am J Physiol Lung Cell Mol Physiol; 2003 Sep; 285(3):L550-9. PubMed ID: 12902318
    [Abstract] [Full Text] [Related]

  • 10. Roles of different hydrophobic constituents in the adsorption of pulmonary surfactant.
    Wang Z, Hall SB, Notter RH.
    J Lipid Res; 1996 Apr; 37(4):790-8. PubMed ID: 8732779
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity.
    Seeger W, Elssner A, Günther A, Krämer HJ, Kalinowski HO.
    Am J Respir Cell Mol Biol; 1993 Aug; 9(2):213-20. PubMed ID: 8338688
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lung surfactant dysfunction in tuberculosis: effect of mycobacterial tubercular lipids on dipalmitoylphosphatidylcholine surface activity.
    Chimote G, Banerjee R.
    Colloids Surf B Biointerfaces; 2005 Nov 10; 45(3-4):215-23. PubMed ID: 16198543
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.